tiprankstipranks
Adaptimmune Therapeutics (ADAP)
NASDAQ:ADAP
Holding ADAP?
Track your performance easily

Adaptimmune Therapeutics (ADAP) Ownership - Who Owns Adaptimmune Therapeutics?

822 Followers

Recent Insider Trading Activity

Date
Name
Activity
Value

Recent Hedge Fund Trading Activity

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
102,478,668Insider40.05%61,897,115
37,681,515Institution14.73%22,759,635
19,500,000Insider7.62%11,778,000
2,343,695Institution0.92%1,415,592
1,800,000Insider0.70%1,087,200
397,979Institution0.16%240,379
182,903Institution0.07%110,473
139,801Institution0.05%84,440
130,764Insider0.05%78,981
99,822Institution0.04%60,292

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
139,801Institution0.05%84,440
99,822Institution0.04%60,292
16,257Institution<0.01%9,819
6,385Institution<0.01%3,857
554Institution<0.01%335

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
251,080Institution0.10%150,648
182,903Institution0.07%109,742
146,899Institution0.06%88,139
33,721Institution0.01%20,398

FAQ

Who Owns Adaptimmune Therapeutics (ADAP)?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by institutional investors?
Currently, no data Available
What percentage of Adaptimmune Therapeutics (ADAP) stock is held by retail investors?
Currently, no data Available
Who owns the most shares of Adaptimmune Therapeutics (ADAP)?
David Mott owns the most shares of Adaptimmune Therapeutics (ADAP).
    What is the significance of the ownership structure for a publicly traded company?
    The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
      What am I Missing?
      Make informed decisions based on Top Analysts' activity
      Know what industry insiders are buying
      Get actionable alerts from top Wall Street Analysts
      Find out before anyone else which stock is going to shoot up
      Get powerful stock screeners & detailed portfolio analysis